Cargando…
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974748/ https://www.ncbi.nlm.nih.gov/pubmed/32010237 http://dx.doi.org/10.1177/1759720X19895490 |
| _version_ | 1783490159405170688 |
|---|---|
| author | Reid, David M. |
| author_facet | Reid, David M. |
| author_sort | Reid, David M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6974748 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69747482020-01-31 Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? Reid, David M. Ther Adv Musculoskelet Dis Editorial SAGE Publications 2020-01-20 /pmc/articles/PMC6974748/ /pubmed/32010237 http://dx.doi.org/10.1177/1759720X19895490 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Editorial Reid, David M. Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? |
| title | Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| title_full | Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| title_fullStr | Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| title_full_unstemmed | Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| title_short | Balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| title_sort | balancing the risks and benefits of biologic drugs in rheumatic
disease: the case for romosozumab? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974748/ https://www.ncbi.nlm.nih.gov/pubmed/32010237 http://dx.doi.org/10.1177/1759720X19895490 |
| work_keys_str_mv | AT reiddavidm balancingtherisksandbenefitsofbiologicdrugsinrheumaticdiseasethecaseforromosozumab |